Metabolic syndrome in Spain: Prevalence and coronary risk associated with harmonized definition and who proposal. DARIOS study;Síndrome metabólico en España: prevalencia y riesgo coronario asociado a la definición armonizada y a la propuesta por la OMS. Estudio DARIOS

Revista Espanola de Cardiologia

Volumn 65, Issue 3, 2012, Pages 241-248

  Fernández Bergés, Daniel ^a   Cabrera De León, Antonio ^b,c   Sanz, Héctor ^d   Elosua, Roberto ^d,e   Guembe, María J ^f,g   Alzamora, Maite ^h,i   Vega Alonso, Tomás ^j   Félix Redondo, Francisco J ^a,k   Ortiz Marrón, Honorato ^l   Rigo, Fernando ^m   Lama, Carmen ^n,o   Gavrila, Diana ^e,p   Segura Fragoso, Antonio ^q   Lozano, Luis ^a   Marrugat, Jaume ^d  

^a Unidad de Investigacion Programa de Investigacion en Enfermedades Cardiovasculares PERICLES   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f Servicio de Docencia y Desarrollo Sanitarios   (Spain)

^g Grupo de Investigación Riesgo Vascular en Navarra RIVANA   (Spain)

^h INSTITUT CATALÀ DE LA SALUT   (Spain)

ⁱ Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^j Castile and León   (Spain)

^k Centro de Salud Villanueva Norte   (Spain)

^l Servicio Madrileño de Salud Red de Investigación en Servicios de Salud en Enfermedades Crónicas   (Spain)

^m UB Genova   (Spain)

ⁿ Servicio Andaluz de Salud   (Spain)

^o Instituto de Salud Carlos III   (Spain)

^p Servicio de Epidemiología   (Spain)

^q Servicio de Laboratorio   (Spain)

more..

Author keywords

Cardiovascular disease; Diabetes mellitus; Metabolic syndrome; Risk scores

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; CORONARY RISK; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; REVIEW; SPAIN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84857507125     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.10.015     Document Type: Article

References (35)

1. M. Hanefeld, and W. Leonhardt Das metabolische Syndrom Dtsch Gesundheitwes 36 1981 545 551
2. G.M. Reaven The metabolic syndrome: requiescat in pace Clin Chem 51 2005 931 938 (Pubitemid 40740871)
3. R. Kahn, J. Buse, E. Ferrannini, M. Stern American Diabetes Association; European Association for the Study of Diabetes The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 28 2005 2289 2304 (Pubitemid 41242486)
4. K.G.M.M. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, and K.A. Donato Harmonizing the metabolic syndrome. A Joint Interm Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
5. A. Alkerwi, A.F. Donneau, N. Sauvageot, M.L. Lair, A. Scheen, and A. Albert Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study BMC Public Health 11 2011 4
6. R.K. Simmons, K.G. Alberti, A.M. Gale, S. Colagiuri, J. Tuomilehto, and Q. Qiao The metabolic syndrome: useful concept or clinical tool? Diabetologia 53 2010 600 605
7. M. Grau, R. Elosua, A. Cabrera de León, M.J. Guembe, J.M. Baena-Díez, and T. Vega Alonso Factores de riesgo cardiovascular en España en la primera década del siglo xxi: Análisis agrupado con datos individuales de 11 estudios de base poblacional. Estudio DARIOS Rev Esp Cardiol 64 2011 295 304
8. M.M. Finucane, G.A. Stevens, M.J. Cowan, G. Danaei, J.K. Lin, and C.J. Paciorek National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9,1 million participants Lancet 377 2011 557 567
9. Y.M. Farag, and M.R. Gaballa Diabesity: an overview of a rising epidemic Nephrol Dial Transplant 26 2011 28 35
10. O.H. Franco, J.M. Massaro, J. Civil, M.R. Cobain, B. O'Malley, and R.B. D'Agostino Sr. Trajectories of entering the metabolic syndrome: The Framingham Heart Study Circulation 120 2009 1943 1950
11. J. Marrugat, I. Subirana, E. Comín, C. Cabezas, J. Vila, and R. Elosua Validity of an adaptation of the Framingham risk function: The VERIFICA Study J Epidemiol Community Health 61 2007 40 47 (Pubitemid 46114588)
12. O.E. Ahmad, C. Boschi-Pinto, A.D. López, C.J.L. Murray, R. Lozano, and M. Inoue Age standardization of rates: a new WHO standard GPE Discussion Paper Series: No. 31 2000 World Health Organization Geneva
13. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
14. E.S. Ford, C. Li, and G. Zhao Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US J Diabetes 2 2010 180 193
15. J. Ren, and R.O. Kelley Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology Obesity (Silver Spring) 17 2009 1114 1123
16. Q. Qiao DECODE Study Group Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women Diabetologia 49 2006 2837 2846 (Pubitemid 44730285)
17. J. Müller-Nordhorn, S. Binting, S. Roll, and S.N. Willich An update on regional variation in cardiovascular mortality within Europe Eur Heart J 29 2008 1316 1326 (Pubitemid 351768126)
18. J.B. Meigs, M.K. Rutter, L.M. Sullivan, C.S. Fox, R.B. D'Agostino Sr., and P.W. Wilson Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome Diabetes Care 30 2007 1219 1225 (Pubitemid 46684651)
19. M.T. Martínez-Larrad, C. Fernández-Pérez, J.L. González-Sánchez, A. López, J. Fernández-Alvarez, and J. Riviriego Prevalencia del síndrome metabólico (criterios del ATP III). Estudio de base poblacional en áreas rural y urbana de la provincia de Segovia Med Clin (Barc) 125 2005 481 486 (Pubitemid 41695875)
20. Calbo Mayo, I. Terrancle de Juan, P. Fernández Jiménez, M.J. Rodríguez Martín, V. Martínez Díaz, and Y. Santisteban López Prevalencia del síndrome metabólico en la provincia de Albacete Rev Clin Esp 207 2007 64 68 (Pubitemid 46474379)
21. A. López Suárez, J. Elvira González, M. Beltrán Robles, M. Alwakil, J.M. Saucedo, and A. Bascuñana Quirell Prevalencia de obesidad, diabetes, hipertensión, hipercolesterolemia y síndrome metabólico en adultos mayores de 50 años de Sanlúcar de Barrameda Rev Esp Cardiol 61 2008 1150 1158
22. J.J. Cabré, F. Martín, B. Costa, J.L. Piñol, J.L. Llor, and Y. Ortega Metabolic syndrome as a cardiovascular disease risk factor: patients evaluated in primary care BMC Public Health 8 2008 251
23. E.E. Álvarez León, L. Ribas Barba, and L. Serra Majem Prevalencia del síndrome metabólico en la población de la Comunidad Canaria Med Clin (Barc) 120 2003 172 174 (Pubitemid 36266971)
24. K. Casazza, A. Dulin-Keita, B.A. Gower, and J.R. Fernandez Differential influence of diet and physical activity on components of metabolic syndrome in a multiethnic sample of children J Am Diet Assoc 109 2009 236 244
25. A. Jover, E. Corbella, A. Muñoz, J. Millán, X. Pintó, and A. Mangas Prevalencia del síndrome metabólico y de sus componentes en pacientes con síndrome coronario agudo Rev Esp Cardiol 64 2011 579 586
26. P.E. Gustafsson, M. Persson, and A. Hammarström Life course origins of the metabolic syndrome in middle-aged women and men: the role of socioeconomic status and metabolic risk factors in adolescence and early adulthood Ann Epidemiol 21 2011 103 110
27. E.A. El Bassuoni, D.C. Ziemer, P. Kolm, M.K. Rhee, V. Vaccarino, and C.W. Tsui The "metabolic syndrome" is less useful than random plasma glucose to screen for glucose intolerance Prim Care Diabetes 2 2008 147 153
28. A. Mente, S. Yusuf, S. Islam, M.J. McQueen, S. Tanomsup, and C.L. Onen Metabolic syndrome and risk of acute myocardial infarction J Am Coll Cardiol 55 2010 2390 2398
29. A.J. Cameron, D.J. Magliano, P.Z. Zimmet, T.A. Welborn, S. Colagiuri, and A.M. Tonkin The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study J Intern Med 264 2008 177 186 (Pubitemid 351962573)
30. M.J. Guembe, E. Toledo, J. Barba, E. Martínez-Vila, P. González-Diego, and P. Irimia Association between metabolic syndrome or its components and asymptomatic cardiovascular disease in the RIVANA-study Atherosclerosis 211 2010 612 617
31. S. Mottillo, K.B. Filion, J. Genest, L. Joseph, L. Pilote, and P. Poirier The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
32. G.R. Hajer, T.W. Van Haeften, and F.L.J. Visseren Adipose tissue dysfunction in obesity, diabetes, and vascular diseases Eur Heart J 29 2008 2959 2971
33. R.H. Unger, and P.E. Scherer Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity Trends Endocrinol Metab 21 2010 345 352
34. M.F. Landecho, I. Colina, A. Huerta, A. Fortuño, G. Zalba, and O. Beloqui Relación entre las fases precoces de la enfermedad renal y el síndrome metabólico Rev Esp Cardiol 64 2011 373 378
35. L.O. Lerman, and A. Lerman El síndrome metabólico y la enfermedad renal temprana: ¿un eslabón más de la cadena? Rev Esp Cardiol 64 2011 358 360